KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Sep 2025 value amounting to $7.6 billion.

  • Jazz Pharmaceuticals' Non-Current Assets fell 3.37% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year decrease of 3.37%. This contributed to the annual value of $7.4 billion for FY2024, which is 7.22% down from last year.
  • Jazz Pharmaceuticals' Non-Current Assets amounted to $7.6 billion in Q3 2025, which was up 0.09% from $7.6 billion recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Non-Current Assets peaked at $10.3 billion during Q2 2021, and registered a low of $3.6 billion during Q1 2021.
  • For the 3-year period, Jazz Pharmaceuticals' Non-Current Assets averaged around $7.8 billion, with its median value being $7.8 billion (2024).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 172.55% in 2021, then dropped by 20.68% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Non-Current Assets (Quarterly) stood at $9.7 billion in 2021, then dropped by 15.05% to $8.2 billion in 2022, then fell by 3.30% to $8.0 billion in 2023, then decreased by 7.22% to $7.4 billion in 2024, then fell by 3.37% to $7.6 billion in 2025.
  • Its Non-Current Assets stands at $7.6 billion for Q3 2025, versus $7.6 billion for Q2 2025 and $7.4 billion for Q1 2025.